308 related articles for article (PubMed ID: 15742626)
1. Successful control of Marek's disease by vaccination.
Nair V
Dev Biol (Basel); 2004; 119():147-54. PubMed ID: 15742626
[TBL] [Abstract][Full Text] [Related]
2. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?
Davison F; Nair V
Expert Rev Vaccines; 2005 Feb; 4(1):77-88. PubMed ID: 15757475
[TBL] [Abstract][Full Text] [Related]
3. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
Baigent SJ; Smith LP; Nair VK; Currie RJ
Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
[TBL] [Abstract][Full Text] [Related]
4. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
[TBL] [Abstract][Full Text] [Related]
6. Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens.
Cui HY; Wang YF; Shi XM; An TQ; Tong GZ; Lan DS; He L; Liu CJ; Wang M
J Virol Methods; 2009 Mar; 156(1-2):66-72. PubMed ID: 19026690
[TBL] [Abstract][Full Text] [Related]
7. Effect of diluting Marek's disease vaccines on the outcomes of Marek's disease virus infection when challenged with highly virulent Marek's disease viruses.
Gimeno IM; Cortes AL; Montiel ER; Lemiere S; Pandiri AK
Avian Dis; 2011 Jun; 55(2):263-72. PubMed ID: 21793444
[TBL] [Abstract][Full Text] [Related]
8. The long view: 40 years of Marek's disease research and Avian Pathology.
Biggs PM; Nair V
Avian Pathol; 2012; 41(1):3-9. PubMed ID: 22845316
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV.
Lee LF; Lupiani B; Silva RF; Kung HJ; Reddy SM
Vaccine; 2008 Mar; 26(15):1887-92. PubMed ID: 18313812
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
[TBL] [Abstract][Full Text] [Related]
12. Expression of chicken interleukin-2 by turkey herpesvirus increases the immune response against Marek's disease virus but fails to increase protection against virulent challenge.
Tarpey I; Davis PJ; Sondermeijer P; van Geffen C; Verstegen I; Schijns VE; Kolodsick J; Sundick R
Avian Pathol; 2007 Feb; 36(1):69-74. PubMed ID: 17364512
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive effects of Marek's disease virus (MDV) and herpesvirus of turkeys (HVT) in broiler chickens and the protective effect of HVT vaccination against MDV challenge.
Islam AF; Wong CW; Walkden-Brown SW; Colditz IG; Arzey KE; Groves PJ
Avian Pathol; 2002 Oct; 31(5):449-61. PubMed ID: 12427339
[TBL] [Abstract][Full Text] [Related]
14. Marek's disease virus: lytic replication, oncogenesis and control.
Jarosinski KW; Tischer BK; Trapp S; Osterrieder N
Expert Rev Vaccines; 2006 Dec; 5(6):761-72. PubMed ID: 17184215
[TBL] [Abstract][Full Text] [Related]
15. Effects of vaccine dose, virus challenge dose and interval from vaccination to challenge on protection of broiler chickens against Marek's disease virus challenge.
Islam AF; Walkden-Brown SW; Groves PJ; Underwood GJ
Aust Vet J; 2007 Sep; 85(9):348-55. PubMed ID: 17760936
[TBL] [Abstract][Full Text] [Related]
16. Biocharacteristics shared by highly protective vaccines against Marek's disease.
Gimeno IM; Witter RL; Hunt HD; Reddy SM; Reed WM
Avian Pathol; 2004 Feb; 33(1):59-68. PubMed ID: 14681069
[TBL] [Abstract][Full Text] [Related]
17. Addition of a UL5 helicase-primase subunit point mutation eliminates bursal-thymic atrophy of Marek's disease virus ∆Meq recombinant virus but reduces vaccinal protection.
Hildebrandt E; Dunn JR; Cheng HH
Avian Pathol; 2015; 44(4):254-8. PubMed ID: 25968878
[TBL] [Abstract][Full Text] [Related]
18. Comparison of blood and feather pulp samples for the diagnosis of Marek's disease and for monitoring Marek's disease vaccination by real time-PCR.
Cortes AL; Montiel ER; Lemiere S; Gimeno IM
Avian Dis; 2011 Jun; 55(2):302-10. PubMed ID: 21793449
[TBL] [Abstract][Full Text] [Related]
19. Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease.
Baaten BJ; Butter C; Davison TF
Vet Immunol Immunopathol; 2004 Aug; 100(3-4):165-77. PubMed ID: 15207454
[TBL] [Abstract][Full Text] [Related]
20. Marek's disease virus: from miasma to model.
Osterrieder N; Kamil JP; Schumacher D; Tischer BK; Trapp S
Nat Rev Microbiol; 2006 Apr; 4(4):283-94. PubMed ID: 16541136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
